INTERNATIONAL BUSINESS MACHINES CORP

IBM

Explore Our Financial Data > Companies > INTERNATIONAL BUSINESS MACHINES CORP

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	IBM
CIK	0000051143
SIC	3570
Sector	Manufacturing
Industry Category	Computer Hardware
Industry Group	Computer & Office Equipment

Contact

Address	1 NEW ORCHARD ROAD, ARMONK, NY, 10504
Website	ibm.com
Phone	9144991900
CEO	Arvind Krishna
Employees	311,300

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$62.83 billion
Pre-Tax Income	$5.88 billion
Net Income	$5.47 billion
Net Income to Common	$5.47 billion
EPS	$5.83

View All

Balance Sheet

Cash	$11.04 billion
Assets	$145.67 billion
Liabilities	$118.71 billion
Common Equity	$26.88 billion
Liabilities & Equity	$145.67 billion

View All

Cash Flow Statement

Net Income	$5.47 billion
Cash From Operating Activities	$13.65 billion
Cash From Investing Activities	$-13.71 billion
Cash From Financing Activities	$-3.51 billion
Change in Cash	$-3.60 billion

View All

Calculations

NOPAT	$7.12 billion
EBITDA	$12.33 billion
Price to Earnings	$48.54
Price to Book	$9.88
ROE	21.77%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Device-as-a-Service (DaaS) Market Set to Soar with 26.90% CAGR, Projected to Reach US$ 233.2 Billion by 2032 Amid Growing Demand for Scalable and Cost-Effective IT Solutions: AnalystView Market Insights

Leading players such as Accenture, Dell Technologies, and IBM significantly influence the trajectory of the DaaS market. These industry frontrunners capitalize on robust R&D capabilities, expansive product portfolios, and strategic market positioning to sustain their competitive advantage and drive innovation across the sector.San Francisco, USA, July 17, 2025 (GLOBE NEWSWIRE) -- The Device-as-a-Service (DaaS) market was valued at USD 34,680.33 million in 2024 and is projected to grow at a CAGR

Article Link

The Zacks Analyst Blog Highlights Exxon Mobil, Home Depot, IBM and Friedman Industries

XOM, HD, IBM, and FRD show resilience with production, digital strategy, AI growth, and capital discipline amid macro headwinds.

Article Link

Appian Appoints David Crozier as Chief Marketing Officer

Appian (NASDAQ: APPN), today announced the appointment of David Crozier to the position of Chief Marketing Officer, effective July 21, 2025. He will report to Appian's CEO, Matt Calkins.

Article Link

Winners in 2025 Stevie® Awards for Great Employers Announced

Winners in the 2025 (10th annual) Stevie® Awards for Great Employers were announced today. The awards recognize the world's best employers and the human resources professionals, teams, achievements, and HR-related products and suppliers who help to create and drive great places to work.

Article Link

IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine.

International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum computing’s promise in medicine. While Moderna isn’t looking to replace classical computing with quantum entirely, the company is interested in building a “quantum-enabled biotechnology pipeline.” If that terminology rings a bell, it’s because that same mRNA approach is central to Moderna’s Covid-19 vaccine.

Article Link